| Long-term therapy of coronary artery disease: a vascular biology perspective. | |
| | |
MedLine Citation:
|
PMID: 11191116 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
When evaluating a patient with known coronary artery disease or a patient with hypercholesterolemia without overt clinical symptoms of coronary artery disease or other vascular disease, it is helpful to understand the vascular biology behind primary and secondary prevention. This article reviews the progression of the atherosclerotic plaque, endothelial function, and the impact of current modes of therapy. |
| | |
Authors:
|
A J Mathé; M B Clearfield |
Related Documents
:
|
12439436 - Coronary artery calcium scoring using electron-beam computed tomography: where does thi... 16934006 - Gata2 is associated with familial early-onset coronary artery disease. 16446736 - Experimental models of arteriogenesis: differences and implications. 7813076 - Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. 15694976 - Short peripheral venous catheters: effect of evidence-based guidelines on insertion, ma... 2114066 - Cromolyn sodium does not inhibit hypoxic pulmonary vasoconstriction in sheep. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Journal of the American Osteopathic Association Volume: 100 ISSN: 0098-6151 ISO Abbreviation: J Am Osteopath Assoc Publication Date: 2000 Nov |
Date Detail:
|
Created Date: 2001-01-17 Completed Date: 2001-02-15 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7503065 Medline TA: J Am Osteopath Assoc Country: United States |
Other Details:
|
Languages: eng Pagination: S13-6 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth/Texas College of Osteopathic Medicine, 3500 Camp Bowie Blvd, Fort Worth, TX 76107-2644, USA. ajmathe@hsc.unt.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticholesteremic Agents
/
therapeutic use Coronary Artery Disease / drug therapy Coronary Disease / drug therapy* Disease Progression Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use Hypercholesterolemia / drug therapy Platelet Aggregation Inhibitors / therapeutic use Risk Factors Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Anticholesteremic Agents; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Platelet Aggregation Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The clinical spectrum of acute coronary syndromes.
Next Document: The venous side: current directions in anticoagulant therapy.